Browse by UCL people
Group by: Type | Date
Jump to: Article
Number of items: 169.
Article
Agius, R;
Brieghel, C;
Andersen, MA;
Pearson, AT;
Ledergerber, B;
Cozzi-Lepri, A;
Louzoun, Y;
... Niemann, CU; + view all
(2020)
Machine learning can identify newly diagnosed patients with CLL at high risk of infection.
Nature Communications
, 11
, Article 363. 10.1038/s41467-019-14225-8.
|
 |
|
Amele, S;
Sandri, AK;
Rodger, A;
Vandekerckhove, L;
Benfield, T;
Milinkovic, A;
Duvivier, C;
... Peters, L; + view all
(2022)
HCV reinfection after HCV therapy among HIV/HCV-coinfected individuals in Europe.
HIV Medicine
, 23
(6)
pp. 684-692.
10.1111/hiv.13212.
|
|
Amele, S;
Peters, L;
Sluzhynska, M;
Yakovlev, A;
Scherrer, A;
Domingo, P;
Gerstoft, J;
... EuroSIDA study group, .; + view all
(2019)
Establishing a hepatitis C continuum of care among HIV/hepatitis C virus‐coinfected individuals in EuroSIDA.
HIV Medicine
, 20
(4)
pp. 264-273.
10.1111/hiv.12711.
|
|
Antinori, Andrea;
Cicalini, Stefania;
Meschi, Silvia;
Bordoni, Veronica;
Lorenzini, Patrizia;
Vergori, Alessandra;
Lanini, Simone;
... HIV-VAC Study Group, .; + view all
(2022)
Humoral and cellular immune response elicited by mRNA vaccination against SARS-CoV-2 in people living with HIV (PLWH) receiving antiretroviral therapy (ART) according with current CD4 T-lymphocyte count.
Clinical Infectious Diseases
10.1093/cid/ciac238.
(In press).
|
|
|
Armenia, D;
Di Carlo, D;
Cozzi-Lepri, A;
Calcagno, A;
Borghi, V;
Gori, C;
Bertoli, A;
... ICONA Foundation Study Group; + view all
(2019)
Very high pre-therapy viral load is a predictor of virological rebound in HIV-1-infected patients starting a modern first-line regimen.
Antiviral Therapy
10.3851/IMP3309.
(In press).
|
|
Atkinson, A;
Miro, JM;
Mocroft, A;
Reiss, P;
Kirk, O;
Morlat, P;
Ghosn, J;
... Opportunistic Infections Working Group of the Collaboration of O, .; + view all
(2021)
No need for secondary Pneumocystis jirovecii pneumonia prophylaxis in adult people living with HIV from Europe on ART with suppressed viraemia and a CD4 cell count greater than 100 cells/µL.
Journal of the International AIDS Society
, 24
(6)
, Article e25726. 10.1002/jia2.25726.
|
|
|
Bai, F;
Tavelli, A;
Mule, G;
Falcinella, C;
Mondatore, D;
Tesoro, D;
Barbanotti, D;
... D'Arminio Monforte, A; + view all
(2021)
A Quantitative Estimate of the Expected Shortening of the Median Isolation Period of Patients With COVID-19 After the Adoption of a Symptom-Based Strategy.
Frontiers in Public Health
, 9
, Article 639347. 10.3389/fpubh.2021.639347.
|
|
|
Bandera, A;
Lorenzini, P;
Taramasso, L;
Cozzi-Lepri, A;
Lapadula, G;
Mussini, C;
Saracino, A;
... Icona Foundation Cohort; + view all
(2021)
The impact of DAA-mediated HCV eradication on CD4+ and CD8+ T lymphocyte trajectories in HIV/HCV coinfected patients: data from the ICONA Foundation Cohort.
Journal of Viral Hepatitis
, 28
(5)
pp. 779-786.
10.1111/jvh.13488.
|
|
Baxter, JD;
Dunn, D;
Tostevin, A;
Marvig, RL;
Bennedbaek, M;
Cozzi-Lepri, A;
Sharma, S;
... Lundgren, J; + view all
(2021)
Transmitted HIV-1 drug resistance in a large international cohort using next-generation sequencing: results from the Strategic Timing of Antiretroviral Treatment (START) study.
HIV Medicine
, 22
(5)
pp. 360-371.
10.1111/hiv.13038.
|
|
Béguelin, C;
Atkinson, A;
Boyd, A;
Falconer, K;
Kirkby, N;
Suter-Riniker, F;
Günthard, HF;
... Stefan, C; + view all
(2023)
Hepatitis delta infection among persons living with HIV in Europe.
Liver International
10.1111/liv.15519.
(In press).
|
|
Bouteloup, V;
Sabin, C;
Mocroft, A;
Gras, L;
Pantazis, N;
Le Moing, V;
d'Arminio Monforte, A;
... Standard Reference Distribution of CD4 Response to HAART Project, .; + view all
(2017)
Reference curves for CD4 T-cell count response to combination antiretroviral therapy in HIV-1-infected treatment-naive patients.
HIV Medicine
, 18
(1)
pp. 33-44.
10.1111/hiv.12389.
|
|
Brancaccio, Giuseppina;
Shanyinde, Milensu;
Puoti, Massimo;
Gaeta, Giovanni B;
Monforte, Antonella D'Arminio;
Vergori, Alessandra;
Rusconi, Stefano;
... ICONA Foundation Cohort; + view all
(2023)
Hepatitis delta coinfection in persons with HIV: misdiagnosis and disease burden in Italy.
Pathogens and Global Health
, 117
(2)
pp. 181-189.
10.1080/20477724.2022.2047551.
|
|
Burani, Elisa;
Marruganti, Sharon;
Giglioni, Gloria;
Bonetti, Francesca;
Ceron, Daniele;
Cozzi Lepri, Alessandro;
(2023)
Predictive Factors for Pregnancy-Related Persistent Pelvic Girdle Pain (PPGP): A Systematic Review.
Medicina
, 59
(12)
, Article 2123. 10.3390/medicina59122123.
|
|
Busani, S;
Bedini, A;
Biagioni, E;
Serio, L;
Tonelli, R;
Meschiari, M;
Franceschini, E;
... Modena Covid-19 Working Group (MoCo19); + view all
(2021)
Two Fatal Cases of Acute Liver Failure Due to HSV-1 Infection in COVID-19 Patients Following Immunomodulatory Therapies.
Clinical Infectious Diseases
, 73
(1)
e252-e255.
10.1093/cid/ciaa1246.
|
|
|
Caputo, Sergio Lo;
Poliseno, Mariacristina;
Tavelli, Alessandro;
Gagliardini, Roberta;
Rusconi, Stefano;
Lapadula, Giuseppe;
Antinori, Andrea;
... ICONAFoundationStudy Group, .; + view all
(2024)
Heavily Treatment-Experienced Persons Living with HIV Currently in Care in Italy: characteristics, Risk Factors, and Therapeutic Options - the ICONA Foundation Cohort study.
International Journal of Infectious Diseases
, 143
, Article 106956. 10.1016/j.ijid.2024.01.023.
|
|
Casadellà, M;
Cozzi-Lepri, A;
Phillips, A;
Noguera-Julian, M;
Bickel, M;
Sedlacek, D;
Zilmer, K;
... EuroSIDA in EuroCOORD, .; + view all
(2017)
Plasma HIV-1 Tropism and the Risk of Short-Term Clinical Progression to AIDS or Death.
PLOS One
, 12
(1)
, Article e0166613. 10.1371/journal.pone.0166613.
|
|
|
Castagna, A;
Monno, L;
Carta, S;
Galli, L;
Carrara, S;
Fedele, V;
Punzi, G;
... Monforte, AD; + view all
(2016)
Switch of predicted HIV-1 tropism in treated subjects and its association with disease progression.
Medicine
, 95
(44)
, Article e5222. 10.1097/MD.0000000000005222.
|
|
|
Ceccherini-Silberstein, F;
Cozzi Lepri, A;
Alteri, C;
Merlini, E;
Surdo, M;
Marchetti, G;
Capobianchi, MR;
... ICONA Foundation Study Group; + view all
(2018)
Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline viro-immunological status and outcome in patients under first-line ART.
Journal of Antimicrobial Chemotherapy
10.1093/jac/dky350.
|
|
|
Cervo, Adriana;
Russo, Antonio;
Di Carlo, Domenico;
De Vito, Andrea;
Fabeni, Lavinia;
D'Anna, Stefano;
Duca, Leonardo;
... Santoro, Maria Mercedes; + view all
(2023)
Long-acting combination of cabotegravir plus rilpivirine: A picture of potential eligible and ineligible HIV-positive individuals from the Italian ARCA cohort.
Journal of Global Antimicrobial Resistance
, 34
pp. 141-144.
10.1016/j.jgar.2023.07.006.
|
|
|
Chammartin, F;
Lodi, S;
Logan, R;
Ryom, L;
Mocroft, A;
Kirk, O;
Monforte, AD;
... Bucher, HC; + view all
(2021)
Risk for Non-AIDS-Defining and AIDS-Defining Cancer of Early Versus Delayed Initiation of Antiretroviral Therapy A Multinational Prospective Cohort Study.
Annals of Internal Medicine
, 174
(6)
pp. 768-776.
10.7326/M20-5226.
|
|
Chereau, F;
Madec, Y;
Sabin, C;
Obel, N;
Ruiz-Mateos, E;
Chrysos, G;
Fidler, S;
... HIV Controllers Project Working Group for the Collaboration of O; + view all
(2017)
Impact of CD4 and CD8 dynamics and viral rebounds on loss of virological control in HIV controllers.
PLoS One
, 12
(4)
, Article e0173893. 10.1371/journal.pone.0173893.
|
|
Cingolani, A;
Tavelli, A;
Calvino, GV;
Maggiolo, F;
Girardi, E;
Cozzi-Lepri, A;
Perziano, A;
... for ICONA Foundation Study Group; + view all
(2023)
Awareness and perception of accuracy of the Undetectable=Untransmittable message (U=U) in Italy: results from a survey among PLWHA, infectious-diseases physicians and people having unprotected sex.
AIDS Care
, 35
(6)
pp. 923-933.
10.1080/09540121.2022.2074960.
|
|
Cingolani, A;
Lepri, AC;
Teofili, L;
Galli, L;
Mazzotta, V;
Baldin, GM;
Hohaus, S;
... Antinori, A; + view all
(2017)
Survival and predictors of death in people with HIV-associated lymphoma compared to those with a diagnosis of lymphoma in general population.
PLoS ONE
, 12
(10)
, Article e0186549. 10.1371/journal.pone.0186549.
|
|
|
Cingolani, A;
Zona, S;
Girardi, E;
Cozzi-Lepri, A;
Monno, L;
Quiros Roldan, E;
Guaraldi, G;
... Marcotullio, S; + view all
(2015)
Incidence and factors associated with the risk of sexually transmitted diseases in HIV-infected people seen for care in Italy: data from the Icona Foundation cohort.
HIV Medicine
, 16
(7)
pp. 412-420.
10.1111/hiv.12226.
|
|
|
Coloretti, I;
Busani, S;
Biagioni, E;
Venturelli, S;
Munari, E;
Sita, M;
Dall'Ara, L;
... Serpini, GF; + view all
(2021)
Effects of cytokine blocking agents on hospital mortality in patients admitted to ICU with acute respiratory distress syndrome by SARS-CoV-2 infection: Retrospective cohort study.
Multidisciplinary Respiratory Medicine
, 16
10.4081/mrm.2021.737.
|
|
|
Cossarizza, A;
Cozzi-Lepri, A;
Mattioli, M;
Paolini, A;
Neroni, A;
De Biasi, S;
Tartaro, DL;
... Mussini, C; + view all
(2023)
Evaluating immunological and inflammatory changes of treatment-experienced people living with HIV switching from first-line triple cART regimens to DTG/3TC vs. B/F/TAF: the DEBATE trial.
Frontiers in Immunology
, 14
, Article 1279390. 10.3389/fimmu.2023.1279390.
|
|
|
Costarelli, S;
Cozzi-Lepri, A;
Lapadula, G;
Bonora, S;
Madeddu, G;
Maggiolo, F;
Antinori, A;
... ICONA Foundation Study Group; + view all
(2016)
Long-Term Durability of Tenofovir-Based Antiretroviral Therapy in Relation to the Co-Administration of Other Drug Classes in Routine Clinical Practice.
PLoS One
, 11
(10)
, Article e0160761. 10.1371/journal.pone.0160761.
|
|
Cozzi-Lepri, A;
Smith, C;
Mussini, C;
(2022)
Signals were broadly positive for months, but never definitive: the tocilizumab story.
Clinical Microbiology and Infection
, 28
(3)
pp. 371-374.
10.1016/j.cmi.2021.10.018.
|
|
Cozzi-Lepri, Alessandro;
Borghi, Vanni;
Rotundo, Salvatore;
Mariani, Bianca;
Ferrari, Anna;
Del Borgo, Cosmo;
Bai, Francesca;
... Mussini, Cristina; + view all
(2024)
Development and validation of a prediction score for failure to casirivimab/imdevimab in hospitalized patients with COVID-19 pneumonia.
Frontiers in Medicine
, 11
, Article 1293431. 10.3389/fmed.2024.1293431.
|
|
Cozzi-Lepri, Alessandro;
Dunn, David;
Tostevin, Anna;
Marvig, Rasmus L;
Bennedbaek, Marc;
Sharma, Shweta;
Kozal, Michael J;
... INSIGHT START Study Group, Group; + view all
(2023)
Rate of response to initial antiretroviral therapy according to level of pre-existing HIV-1 drug resistance detected by next-generation sequencing in the strategic timing of antiretroviral treatment (START) study.
HIV Medicine
10.1111/hiv.13556.
(In press).
|
|
Cozzi-Lepri, Alessandro;
Peters, Lars;
Pelchen-Matthews, Annegret;
Neesgaard, Bastian;
De Wit, Stephane;
Johansen, Isik Somuncu;
Edwards, Simon;
... EuroSIDA Study Group; + view all
(2022)
Observational cohort study of rilpivirine (RPV) utilization in Europe.
AIDS Research and Therapy
, 19
, Article 38. 10.1186/s12981-022-00457-0.
|
 |
|
Cozzi-Lepri, Alessandro;
Tavelli, Alessandro;
Taramasso, Lucia;
Lapadula, Giuseppe;
Bobbio, Nicoletta;
Piconi, Stefania;
Guaraldi, Giovanni;
... Icona Foundation Study group; + view all
(2025)
Selected comorbidities and the probability of ART switch in PWH with undetectable HIV-RNA: a retrospective analysis in Italy.
Journal of Antimicrobial Chemotherapy
, Article dkaf137. 10.1093/jac/dkaf137.
(In press).
|
|
Cozzi-Lepri, A;
De Luca, A;
Phillips, AN;
Bongiovanni, M;
Di Giambenedetto, S;
Mena, M;
Moioli, MC;
... IMIT Study Grp; + view all
(2006)
A comparison between abacavir and efavirenz as the third drug used in combination with a background therapy regimen of 2 nucleoside reverse-transcriptase inhibitors in patients with initially suppressed viral loads.
JOURNAL OF INFECTIOUS DISEASES
, 194
(1)
20 - 28.
|
|
|
Cozzi-Lepri, A;
Guaraldi, G;
Meschiari, M;
Mussini, C;
(2021)
Re: 'methodological evaluation of bias in observational COVID-19 studies on drug effectiveness' by Wolkewitz et al.
[Letter].
Clinical Microbiology and Infection
10.1016/j.cmi.2021.04.026.
(In press).
|
|
|
Cozzi-Lepri, A;
Prosperi, MC;
Kjær, J;
Dunn, D;
Paredes, R;
Sabin, CA;
Lundgren, JD;
... United Kingdom CHIC/United Kingdom HDRD Study; + view all
(2011)
Can linear regression modeling help clinicians in the interpretation of genotypic resistance data? An application to derive a lopinavir-score.
PLOS One
, 6
(11)
, Article e25665. 10.1371/journal.pone.0025665.
|
|
|
Cozzi-Lepri, A;
Zangerle, R;
Machala, L;
Zilmer, K;
Ristola, M;
Pradier, C;
Kirk, O;
... EuroSIDA Study Group, .; + view all
(2017)
Incidence of cancer and overall risk of mortality in individuals treated with raltegravir-based and non-raltegravir-based combination antiretroviral therapy regimens.
HIV Medicine
10.1111/hiv.12557.
(In press).
|
|
|
d'Arminio Monforte, Antonella;
Tavelli, Alessandro;
De Benedittis, Sara;
Bai, Francesca;
Tincati, Camilla;
Gazzola, Lidia;
Viganò, Ottavia;
... For The Spid Group, .; + view all
(2022)
Real World Estimate of Vaccination Protection in Individuals Hospitalized for COVID-19.
Vaccines
, 10
(4)
, Article 550. 10.3390/vaccines10040550.
|
|
d'Arminio Monforte, Antonella;
Tavelli, Alessandro;
Quiros-Roldan, Eugenia;
Fabbiani, Massimiliano;
Ferrara, Micol;
Lo Caputo, Sergio;
Squillace, Nicola;
... Cozzi-Lepri, Alessandro; + view all
(2025)
Predictors for choosing doravirine-based versus INSTI-based regimen in ART-naïve and ART-experienced people with HIV in real-world setting: Data from the Icona cohort.
HIV Medicine
, 26
(3)
pp. 489-499.
10.1111/hiv.13740.
|
|
D'Arminio Monforte, A;
Cozzi-Lepri, A;
Di Biagio, A;
Marchetti, G;
Lo Caputo, S;
Rusconi, S;
Gianotti, N;
... ICONA Foundation Study Group, .; + view all
(2019)
Durability of first-line regimens including integrase strand transfer inhibitors (INSTIs): data from a real-life setting.
Journal of Antimicrobial Chemotherapy
, 74
(5)
pp. 1363-1367.
10.1093/jac/dky566.
|
|
D'Arminio Monforte, A;
Diaz-Cuervo, H;
De Luca, A;
Maggiolo, F;
Cingolani, A;
Bonora, S;
Castagna, A;
... ICONA Foundation Study Group; + view all
(2019)
Evolution of major non‐HIV‐related comorbidities in HIV‐infected patients in the Italian Cohort of Individuals, Naïve for Antiretrovirals (ICONA) Foundation Study cohort in the period 2004–2014.
HIV Medicine
, 20
(2)
pp. 99-109.
10.1111/hiv.12683.
|
|
d'Arminio Monforte, A;
Lorenzini, P;
Cozzi-Lepri, A;
Mussini, C;
Castagna, A;
Baldelli, F;
Puoti, M;
... on behalf of the Icona Foundation Study Group, .; + view all
(2018)
Durability and tolerability of first-line regimens including two nucleoside reverse transcriptase inhibitors and raltegravir or ritonavir boosted-atazanavir or -darunavir: data from the ICONA Cohort.
HIV Clinical Trials
, 19
(2)
pp. 52-60.
10.1080/15284336.2018.1440691.
|
|
D'Arminio Monforte, A;
Tavelli, A;
Bai, F;
Marchetti, G;
Cozzi-Lepri, A;
(2020)
Effectiveness of Hydroxychloroquine in COVID-19 disease: A done and dusted situation?
International Journal of Infectious Diseases
10.1016/j.ijid.2020.07.056.
(In press).
|
|
d'Arminio Monforte, A;
Tavelli, A;
Bai, F;
Tomasoni, D;
Falcinella, C;
Castoldi, R;
Barbanotti, D;
... Marchetti, G; + view all
(2020)
The importance of patients' case-mix for the correct interpretation of the hospital fatality rate in COVID-19 disease.
International Journal of Infectious Diseases
, 100
pp. 67-74.
10.1016/j.ijid.2020.09.037.
|
|
|
d'Arminio Monforte, A;
Tavelli, A;
Cozzi-Lepri, A;
Castagna, A;
Passerini, S;
Francisci, D;
Saracino, A;
... Icona Foundation Study Group, .; + view all
(2020)
Virological response and retention in care according to time of starting ART in Italy: data from the Icona Foundation Study cohort.
Journal of Antimicrobial Chemotherapy
, 75
(3)
pp. 681-689.
10.1093/jac/dkz512.
|
|
d’Arminio Monforte, A;
Tavelli, A;
Rossotti, R;
Gagliardini, R;
Saracino, A;
Lo Caputo, S;
Sala, M;
... Puoti, M; + view all
(2023)
Is HCV elimination among persons living with HIV feasible? Data from the NoCo study in the setting of the ICONA cohort.
Liver International
, 43
(10)
pp. 2130-2141.
10.1111/liv.15700.
|
|
Davey, RT;
Lynfield, R;
Dwyer, DE;
Losso, MH;
Cozzi-Lepri, A;
Wentworth, D;
Lane, HC;
... INSIGHT FLU 002 & 003 Study Groups; + view all
(2013)
The association between serum biomarkers and disease outcome in influenza A(H1N1)pdm09 virus infection: results of two international observational cohort studies.
PLoS One
, 8
(2)
, Article e57121. 10.1371/journal.pone.0057121.
|
|
|
De Luca, A;
Lorenzini, P;
Castagna, A;
Puoti, M;
Gianotti, N;
Castelli, F;
Mastroianni, C;
... ICONA Foundation Study; + view all
(2017)
Active HCV Replication but Not HCV or CMV Seropositive Status Is Associated With Incident and Prevalent Type 2 Diabetes in Persons Living With HIV.
J Acquir Immune Defic Syndr
, 75
(4)
pp. 465-471.
10.1097/QAI.0000000000001443.
|
|
Dentone, C;
Di Biagio, A;
Cozzi Lepri, A;
Fenoglio, D;
Filaci, G;
Lichtner, M;
Carrara, S;
... ICONA Foundation Study Group, .; + view all
(2018)
Inflammatory effects of atazanavir/ritonavir versus darunavir/ritonavir in treatment naïve, HIV-1-infected patients.
HIV Clinical Trials
, 19
(4)
pp. 158-162.
10.1080/15284336.2018.1488453.
|
|
Dwyer, DE;
Lynfield, R;
Losso, MH;
Davey, RT;
Cozzi-Lepri, A;
Wentworth, D;
Uyeki, TM;
... INSIGHT Influenza Study Group, .; + view all
(2017)
Comparison of the Outcomes of Individuals With Medically Attended Influenza A and B Virus Infections Enrolled in 2 International Cohort Studies Over a 6-Year Period: 2009-2015.
Open Forum Infectious Diseases
, 4
(4)
, Article ofx212. 10.1093/ofid/ofx212.
|
|
|
Efsen, AMW;
Panteleev, AM;
Grint, D;
Podlekareva, DN;
Vassilenko, A;
Rakhmanova, A;
Zeltina, I;
... Kirk, O; + view all
(2013)
TB Meningitis in HIV-Positive Patients in Europe and Argentina: Clinical Outcome and Factors Associated with Mortality.
BIOMED RESEARCH INTERNATIONAL
, 2013
(ARTN 373)
10.1155/2013/373601.
|
|
|
Fabeni, L;
Santoro, MM;
Lorenzini, P;
Rusconi, S;
Gianotti, N;
Costantini, A;
Sarmati, L;
... On Behalf Of The Icona Foundation Study Cohort; + view all
(2020)
Evaluation of HIV Transmission Clusters among Natives and Foreigners Living in Italy.
Viruses
, 12
(8)
, Article 791. 10.3390/v12080791.
|
|
|
Fellay, J;
Ge, DL;
Shianna, KV;
Colombo, S;
Ledergerber, B;
Cirulli, ET;
Urban, TJ;
... NIAID Ctr HIV AIDS Vaccine Immunol; + view all
(2009)
Common Genetic Variation and the Control of HIV-1 in Humans.
PLOS GENET
, 5
(12)
, Article e1000791. 10.1371/journal.pgen.1000791.
|
|
|
Franceschini, E;
Cozzi-Lepri, A;
Santoro, A;
Bacca, E;
Lancellotti, G;
Menozzi, M;
Gennari, W;
... Mussini, C; + view all
(2021)
Herpes simplex virus re-activation in patients with SARS-CoV-2 pneumonia: A prospective, observational study.
Microorganisms
, 9
(9)
, Article 1896. 10.3390/microorganisms9091896.
|
|
|
Franceschini, E;
Santoro, A;
Menozzi, M;
Bacca, E;
Venturelli, C;
Zona, S;
Bedini, A;
... Mussini, C; + view all
(2020)
Epidemiology and Outcomes of Bloodstream Infections in HIV-Patients during a 13-Year Period.
Microorganisms
, 8
(8)
, Article 1210. 10.3390/microorganisms8081210.
|
|
|
Frederiksen, CM;
Kjaer, J;
Cozzi-Lepri, A;
Fox, Z;
Lundgren, JD;
(2009)
A bioinformatic approach to identify new potential resistance relevant amino acid substitutions (AAS) in HIV-1 protease (H1P).
Retrovirology
, 6
, Article P38. 10.1186/1742-4690-6-S2-P38.
|
|
|
Gagliardini, R;
Giacomelli, A;
Mussini, C;
Cole, SR;
Edwards, JK;
Pinnetti, C;
Raimondi, A;
... Cozzi-Lepri, A; + view all
(2025)
Effectiveness of dolutegravir-based vs boosted darunavir-based first-line 3-drug regimens in people with HIV with advanced disease: A trial emulation.
International Journal of Infectious Diseases
, 155
, Article 107883. 10.1016/j.ijid.2025.107883.
|
|
Gagliardini, R;
Gianotti, N;
Maggiolo, F;
Cozzi-Lepri, A;
Antinori, A;
Nozza, S;
Lapadula, G;
... ICONA Foundation Study Group, .; + view all
(2021)
Durability of rilpivirine-based versus integrase inhibitor-based regimens in a large cohort of naïve HIV-infected patients starting antiretroviral therapy.
International Journal of Antimicrobial Agents
, 58
(4)
, Article 106406. 10.1016/j.ijantimicag.2021.106406.
|
|
Gagliardini, R;
Tavelli, A;
Rusconi, S;
Lo Caputo, S;
Spagnuolo, V;
Santoro, MM;
Costantini, A;
... Cozzi-Lepri, A; + view all
(2024)
Characterization and outcomes of difficult-to-treat patients starting modern first-line ART regimens: Data from the ICONA cohort.
International Journal of Antimicrobial Agents
, 63
(1)
, Article 107018. 10.1016/j.ijantimicag.2023.107018.
|
|
Gagliardini, Roberta;
Giacomelli, Andrea;
Bozzi, Giorgio;
D'Arminio Monforte, Antonella;
Tavelli, Alessandro;
Mazzotta, Valentina;
Bruzzesi, Elena;
... ICONA Foundation study group; + view all
(2024)
Impact of COVID-19 pandemic on retention in care of native and migrant people with HIV in the ICONA cohort.
Travel Medicine and Infectious Disease
, 58
, Article 102691. 10.1016/j.tmaid.2024.102691.
|
|
|
Gagliardini, Roberta;
Lorenzini, Patrizia;
Cozzi-Lepri, Alessandro;
Tavelli, Alessandro;
Borghi, Vanni;
Galli, Laura;
Tagliaferri, Gianmarco;
... Icona Foundation Study Group; + view all
(2022)
Real world efficacy of dolutegravir plus lamivudine in PLWH with undetectable viral load after previous failures.
Journal of Global Antimicrobial Resistance
10.1016/j.jgar.2022.11.010.
(In press).
|
|
Gagliardini, R;
Cozzi-Lepri, A;
Mariano, A;
Taglietti, F;
Vergori, A;
Abdeddaim, A;
Di Gennaro, F;
... Antinori, A; + view all
(2021)
No Efficacy of the Combination of Lopinavir/Ritonavir Plus Hydroxychloroquine Versus Standard of Care in Patients Hospitalized With COVID-19: A Non-Randomized Comparison.
Frontiers in Pharmacology
, 12
, Article 621676. 10.3389/fphar.2021.621676.
|
|
Gatto, I;
Biagioni, E;
Coloretti, I;
Farinelli, C;
Avoni, C;
Caciagli, V;
Busani, S;
... Serpini, GF; + view all
(2022)
Cytomegalovirus blood reactivation in COVID-19 critically ill patients: risk factors and impact on mortality.
Intensive Care Medicine
, 48
pp. 706-713.
10.1007/s00134-022-06716-y.
|
|
Giacomelli, A;
Cozzi-Lepri, A;
Cingolani, A;
Tavelli, A;
Mazzotta, V;
Tesoro, D;
Bassetti, M;
... ICONA Foundation Study Group, .; + view all
(2021)
Does Syphilis Increase the Risk of HIV-RNA Elevation >200 Copies/mL in HIV-Positive Patients Under Effective Antiretroviral Treatment? Data From the ICONA Cohort.
JAIDS Journal of Acquired Immune Deficiency Syndromes
, 88
(2)
pp. 132-137.
10.1097/QAI.0000000000002749.
|
|
Giacomelli, Andrea;
Antinori, Spinello;
Gori, Andrea;
Cozzi-Lepri, Alessandro;
(2024)
COVID-19: Find the Right Questions to be Answered.
Clinical Infectious Diseases
, 79
(5)
pp. 1322-1323.
10.1093/cid/ciae078.
|
|
Giacomelli, Andrea;
Cozzi-Lepri, Alessandro;
Casalini, Giacomo;
Oreni, Letizia;
Ridolfo, Anna Lisa;
Antinori, Spinello;
(2022)
Estimating the effectiveness of remdesivir on risk of COVID-19 mortality: The role of observational data.
Pharmacological Research
, 181
, Article 106268. 10.1016/j.phrs.2022.106268.
|
|
Giacomelli, Andrea;
Gagliardini, Roberta;
Tavelli, Alessandro;
De Benedittis, Sara;
Mazzotta, Valentina;
Rizzardini, Giuliano;
Mondi, Annalisa;
... COVID-19 ICONA study, group; + view all
(2023)
Risk of COVID-19 in-hospital mortality in people living with HIV compared to general population according to age and CD4 strata: data from the ICONA network.
International Journal of Infectious Diseases
, 136
pp. 127-135.
10.1016/j.ijid.2023.09.015.
|
|
|
Gianotti, N;
Cozzi-Lepri, A;
Antinori, A;
Castagna, A;
De Luca, A;
Celesia, BM;
Galli, M;
... Andreoni, M; + view all
(2017)
Refining criteria for selecting candidates for a safe lopinavir/ritonavir or darunavir/ritonavir monotherapy in HIV-infected virologically suppressed patients.
PLoS ONE
, 12
(2)
, Article e0171611. 10.1371/journal.pone.0171611.
|
|
Gianotti, N;
Lorenzini, P;
Cozzi-Lepri, A;
De Luca, A;
Madeddu, G;
Sighinolfi, L;
Pinnetti, C;
... ICONA Foundation Study Group; + view all
(2019)
Durability of different initial regimens in HIV-infected patients starting antiretroviral therapy with CD4+ counts <200 cells/mm³ and HIV-RNA >5 log₁₀ copies/mL.
Journal of Antimicrobial Chemotherapy
, 74
(9)
pp. 2732-2741.
10.1093/jac/dkz237.
|
|
Gianotti, N;
Marchetti, G;
Antinori, A;
Saracino, A;
Gori, A;
Rizzardini, G;
Lichtner, M;
... Cozzi-Lepri, A; + view all
(2017)
Drop in CD4(+) Counts Below 200 Cells/mu L After Reaching (or Starting From) Values Higher than 350 Cells/mu L in HIV-Infected Patients With Virological Suppression.
JAIDS: Journal of Acquired Immune Deficiency Syndromes
, 76
(4)
pp. 417-422.
10.1097/QAI.0000000000001522.
|
|
Gibellini, L;
De Biasi, S;
Meschiari, M;
Gozzi, L;
Paolini, A;
Borella, R;
Mattioli, M;
... Cossarizza, A; + view all
(2022)
Plasma Cytokine Atlas Reveals the Importance of TH2 Polarization and Interferons in Predicting COVID-19 Severity and Survival.
Frontiers in immunology
, 13
, Article 842150. 10.3389/fimmu.2022.842150.
|
|
|
Girardi, Enrico;
Caro-Vega, Yanink;
Cozzi-Lepri, Alessandro;
Musaazi, Joseph;
Carriquiry, Gabriela;
Castelnuovo, Barbara;
Gori, Andrea;
... Mussini, Cristina; + view all
(2022)
The contribution of late HIV diagnosis on the occurrence of HIV-associated tuberculosis: a 5-year estimate using real-world data.
AIDS
, 36
(14)
pp. 2005-2013.
10.1097/QAD.0000000000003321.
|
|
Grund, B;
Baker, JV;
Deeks, SG;
Wolfson, J;
Wentworth, D;
Cozzi-Lepri, A;
Cohen, CJ;
... Neaton, JD; + view all
(2016)
Relevance of Interleukin-6 and D-Dimer for Serious Non-AIDS Morbidity and Death among HIV-Positive Adults on Suppressive Antiretroviral Therapy.
PLoS One
, 11
(5)
, Article e0155100. 10.1371/journal.pone.0155100.
|
|
Guaraldi, G;
Meschiari, M;
Cozzi-Lepri, A;
(2020)
Tocilizumab in patients with severe COVID-19: a retrospective cohort study- Correction to Lancet Rheumatol 2020; published online June 25. https://doi.org/10.1016/S2665-9913(20)30173-9.
[Corrigendum].
The Lancet Rheumatology
, 2
(10)
, Article e591. 10.1016/S2665-9913(20)30244-7.
|
|
Guaraldi, G;
Meschiari, M;
Cozzi-Lepri, A;
Milic, J;
Tonelli, R;
Menozzi, M;
Franceschini, E;
... Mussini, C; + view all
(2020)
Tocilizumab in patients with severe COVID-19: a retrospective cohort study.
The Lancet Rheumatology
, 2
(8)
e474-e484.
10.1016/S2665-9913(20)30173-9.
|
|
|
Guaraldi, G;
Meschiari, M;
Milic, J;
Cozzi-Lepri, A;
Mussini, C;
(2020)
Tocilizumab for severe COVID-19 pneumonia – Authors' reply.
The Lancet Rheumatology
10.1016/S2665-9913(20)30285-X.
(In press).
|
|
|
Guaraldi, G;
Milic, J;
Cozzi-Lepri, A;
Pea, F;
Mussini, C;
(2020)
Tocilizumab in COVID-19: finding the optimal route and dose – Authors' reply.
The Lancet Rheumatology
, 2
(12)
e739-e740.
10.1016/S2665-9913(20)30333-7.
|
|
Hedberg, P;
Varisco, B;
Bai, F;
Sönnerborg, A;
Naucler, P;
Pfeifer, N;
Cozzi-Lepri, A;
... Marchetti, G; + view all
(2023)
EuCARE-hospitalised study protocol: a cohort study of patients hospitalised with COVID-19 in the EuCARE project.
BMC Infectious Diseases
, 23
, Article 690. 10.1186/s12879-023-08658-2.
|
|
|
Hedberg, Pontus;
Serwin, Karol;
Francesca Greco, Maria;
Pereira, Joana PV;
Juozapaite, Dovile;
De Benedittis, Sara;
Bai, Francesca;
... Nauclér, Pontus; + view all
(2025)
Bacterial and viral co-infections in adult patients hospitalized with COVID-19 throughout the pandemic: A Multinational Cohort Study in the EuCARE Project.
The Journal of Infectious Diseases
, Article jiaf167. 10.1093/infdis/jiaf167.
|
|
Itenov, TS;
Johansen, ME;
Bestle, M;
Thormar, K;
Hein, L;
Gyldensted, L;
Lindhardt, A;
... Cooling and Surviving Septic Shock (CASS) Trial Collaboration, .; + view all
(2018)
Induced hypothermia in patients with septic shock and respiratory failure (CASS): a randomised, controlled, open-label trial.
Lancet Respiratory Medicine
, 6
(3)
pp. 183-192.
10.1016/S2213-2600(18)30004-3.
|
|
Judd, A;
Lodwick, R;
Noguera-Julian, A;
Gibb, DM;
Butler, K;
Costagliola, D;
Sabin, C;
... Pursuing Later Treatment Options II Project Team, .; + view all
(2016)
Higher rates of triple-class virological failure in perinatally HIV-infected teenagers compared with heterosexually infected young adults in Europe.
HIV Medicine
10.1111/hiv.12411.
(In press).
|
|
Kamara, DA;
Ryom, L;
Ross, M;
Kirk, O;
Reiss, P;
Morlat, P;
Moranne, O;
... Smith, CJ; + view all
(2014)
Development of a definition for Rapid Progression (RP) of renal function in HIV-positive persons: the D:A:D study.
BMC Nephrol
, 15
(1)
, Article 51. 10.1186/1471-2369-15-51.
|
|
|
Kelly, ML;
Pinto, AN;
Suan, D;
Marriott, D;
Cooper, DA;
Pett, SL;
(2017)
Managing two decades of visceral leishmaniasis and HIV co-infection: a case report that illustrates the urgent research needs in the field.
Sexual Health
, 14
(3)
pp. 286-288.
10.1071/SH16036.
|
|
Leone, S;
Lorenzini, P;
Cozzi-Lepri, A;
Orofino, G;
Bernacchia, D;
Castagna, A;
Menozzi, M;
... ICONA Foundation Study Group; + view all
(2019)
Impact of diabetes on the risk of serious liver events and liver-related deaths in people living with HIV and hepatitis C co-infection: data from the ICONA Foundation Cohort Study.
European Journal of Clinical Microbiology & Infectious Diseases
, 38
pp. 1857-1865.
10.1007/s10096-019-03618-8.
|
|
Leone, S;
Shanyinde, M;
Cozzi Lepri, A;
Lampe, FC;
Caramello, P;
Costantini, A;
Giacometti, A;
... ICONA Foundation Cohort Study; + view all
(2018)
Incidence and predictors of single drug discontinuation according to the presence of HCV coinfection in HIV patients from the ICONA Foundation Cohort Study.
European Journal of Clinical Microbiology & Infectious Diseases
, 37
(5)
pp. 871-881.
10.1007/s10096-017-3180-8.
|
|
Lepri, AC;
Sabin, CA;
Phillips, AN;
Lee, CA;
Pezzotti, P;
Rezza, G;
(1998)
The rate of CD4 decline as a determinant of progression to AIDS independent of the most recent CD4 count.
EPIDEMIOL INFECT
, 121
(2)
369 - 376.
|
|
|
Llibre, JM;
Cozzi-Lepri, A;
Pedersen, C;
Ristola, M;
Losso, M;
Mocroft, A;
Mitsura, V;
... EuroSIDA Study; + view all
(2016)
Long-term effectiveness of unboosted atazanavir plus abacavir/lamivudine in subjects with virological suppression: A prospective cohort study.
Medicine
, 95
(40)
, Article e5020. 10.1097/MD.0000000000005020.
|
|
|
Lori, EM;
Cozzi-Lepri, A;
Tavelli, A;
Mercurio, V;
Ibba, SV;
Lo Caputo, S;
Castelli, F;
... Biasin, M; + view all
(2020)
Evaluation of the effect of protective genetic variants on cART success in HIV-1-infected patients.
Journal of Biological Regulators and Homeostatic Agents
, 34
(4)
10.23812/19-527-L.
|
|
Madeddu, G;
De Vito, A;
Cozzi-Lepri, A;
Cingolani, A;
Maggiolo, F;
Perno, CF;
Gagliardini, R;
... Girardi, E; + view all
(2021)
Time spent with HIV-RNA ≤ 200 copies/ml in a cohort of people with HIV during the U=U era.
AIDS
, 35
(7)
pp. 1103-1112.
10.1097/QAD.0000000000002825.
|
|
Madeddu, G;
Rusconi, S;
Cozzi-Lepri, A;
Di Giambenedetto, S;
Bonora, S;
Carbone, A;
De Luca, A;
... Antinori, A; + view all
(2017)
Efficacy and tolerability of switching to a dual therapy with darunavir/ritonavir plus raltegravir in HIV-infected patients with HIV-1 RNA <= 50 cp/mL.
Infection
, 45
(4)
pp. 521-528.
10.1007/s15010-017-1018-z.
|
|
Malagnino, Vincenzo;
Cozzi-Lepri, Alessandro;
Svicher, Valentina;
Girardi, Enrico;
Perno, Carlo Federico;
Saracino, Annalisa;
Cuomo, Gianluca;
... ICONA Foundation Study Group; + view all
(2024)
Association between markers of hepatitis B virus infection and risk of virological rebound in people with HIV receiving antiretroviral therapy.
HIV Medicine
, 25
(10)
pp. 1101-1111.
10.1111/hiv.13680.
|
|
Malagnino, V;
Cerva, C;
Cingolani, A;
Ceccherini-Silberstein, F;
Vergori, A;
Cuomo, G;
Perno, CF;
... ICONA Foundation Study Group, .; + view all
(2021)
HBcAb Positivity Increases the Risk of Severe Hepatic Fibrosis Development in HIV/HCV-Positive Subjects From the ICONA Italian Cohort of HIV-Infected Patients.
Open Forum Infectious Diseases
, 8
(1)
, Article ofaa566. 10.1093/ofid/ofaa566.
|
|
|
Mastrorosa, I;
Cozzi-Lepri, A;
Colavita, F;
Lalle, E;
Mazzotta, V;
Cimaglia, C;
Paulicelli, J;
... Antinori, A; + view all
(2022)
SARS-CoV-2 nasopharyngeal viral load in individuals infected with BA.2, compared to Alpha, Gamma, Delta and BA.1 variants: A single-center comparative analysis.
Journal of Clinical Virology
, 157
, Article 105299. 10.1016/j.jcv.2022.105299.
|
|
Matusali, G;
Vergori, A;
Cimini, E;
Mariotti, D;
Mazzotta, V;
Lepri, AC;
Colavita, F;
... Antinori, A; + view all
(2024)
Poor durability of the neutralizing response against XBB sublineages after a bivalent mRNA COVID-19 booster dose in persons with HIV.
Journal of Medical Virology
, 96
(4)
, Article e29598. 10.1002/jmv.29598.
|
|
|
Mazzotta, V;
Cozzi-Lepri, A;
Colavita, F;
Lanini, S;
Rosati, S;
Lalle, E;
Mastrorosa, I;
... Antinori, A; + view all
(2022)
Emulation of a Target Trial From Observational Data to Compare Effectiveness of Casirivimab/Imdevimab and Bamlanivimab/Etesevimab for Early Treatment of Non-Hospitalized Patients With COVID-19.
Frontiers in Immunology
, 13
, Article 868020. 10.3389/fimmu.2022.868020.
|
|
Mazzotta, V;
Cozzi-Lepri, A;
Lanini, S;
Mondi, A;
Carletti, F;
Tavelli, A;
Gagliardini, R;
... Antinori, A; + view all
(2023)
Effect of tecovirimat on healing time and viral clearance by emulation of a target trial in patients hospitalized for mpox.
Journal of medical virology
, 95
(6)
, Article e28868. 10.1002/jmv.28868.
|
|
Mazzotta, V;
Lepri, AC;
Del Borgo, C;
Lanini, S;
Meschi, S;
Garattini, S;
Rosati, S;
... Antinori, A; + view all
(2025)
Comparative Analysis of Early COVID-19 Treatment Efficacy in a Multicentric Regional Cohort in Italy: Emulation of a Series of Target Trials.
Journal of Medical Virology
, 97
(5)
, Article e70379. 10.1002/jmv.70379.
|
|
Mazzotta, Valentina;
Lepri, Alessandro Cozzi;
Matusali, Giulia;
Cimini, Eleonora;
Piselli, Pierluca;
Aguglia, Camilla;
Lanini, Simone;
... Marocco, Raffaella; + view all
(2024)
Immunogenicity and reactogenicity of modified vaccinia Ankara pre-exposure vaccination against mpox according to previous smallpox vaccine exposure and HIV infection: prospective cohort study.
eClinicalMedicine
, 68
, Article 102420. 10.1016/j.eclinm.2023.102420.
|
|
Merlini, E;
Cozzi-lepri, A;
Castagna, A;
Costantini, A;
Lo Caputo, S;
Carrara, S;
Roldan, EQ;
... Marchetti, G; + view all
(2021)
Inflammation and microbial translocation measured prior to combination antiretroviral therapy (cART) and long-term probability of clinical progression in people living with HIV.
BMC Infectious Diseases
, 21
(1)
, Article 557. 10.1186/s12879-021-06260-y.
|
|
|
Meschiari, M;
Cozzi-Lepri, A;
Cervo, A;
Granata, G;
Rogati, C;
Franceschini, E;
Casolari, S;
... Mussini, C; + view all
(2023)
Efficacy of bezlotoxumab in preventing the recurrence of Clostridioides difficile infection: an Italian multicenter cohort study.
International Journal of Infectious Diseases
, 131
pp. 147-154.
10.1016/j.ijid.2023.04.004.
|
|
|
Meschiari, M;
Cozzi-Lepri, A;
Tonelli, R;
Bacca, E;
Menozzi, M;
Franceschini, E;
Cuomo, G;
... Modena COVID-19 Working Group (MoCo19); + view all
(2022)
First and second waves among hospitalised patients with COVID-19 with severe pneumonia: a comparison of 28-day mortality over the 1-year pandemic in a tertiary university hospital in Italy.
BMJ Open
, 12
(1)
, Article e054069. 10.1136/bmjopen-2021-054069.
|
|
Migrant Health Working Group for the Collaboration of Observatio, .;
(2018)
Immunological and virological response to antiretroviral treatment in migrant and native men and women in Western Europe; is benefit equal for all?
HIV Medicine
, 19
(1)
pp. 42-48.
10.1111/hiv.12536.
|
|
Miltz, AR;
Rodger, AJ;
Lepri, AC;
Sewell, J;
Nwokolo, NC;
Allan, S;
Scott, C;
... AURAH Study Group; + view all
(2019)
Investigating Conceptual Models for the Relationship Between Depression and Condomless Sex Among Gay, Bisexual, and Other Men Who have Sex with Men: Using Structural Equation Modelling to Assess Mediation.
AIDS and Behavior
10.1007/s10461-019-02724-0.
(In press).
|
|
|
Mocroft, A;
Miro, JM;
Wandeler, G;
Llibre, JM;
Boyd, A;
van Bremen, K;
Beniowski, M;
... Peters, L; + view all
(2022)
The association between hepatitis B virus infection and nonliver malignancies in persons living with HIV: results from the EuroSIDA study.
HIV Medicine
, 23
(6)
pp. 585-598.
10.1111/hiv.13210.
|
|
Mocroft, A;
Lundgren, JD;
Ross, M;
Law, M;
Reiss, P;
Kirk, O;
Smith, C;
... ESPRIT study group, .; + view all
(2015)
Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study.
PLoS Med
, 12
(3)
, Article e1001809 . 10.1371/journal.pmed.1001809.
|
|
|
Mocroft, A;
Lundgren, JD;
Sabin, ML;
Monforte, AD;
Brockmeyer, N;
Casabona, J;
Castagna, A;
... Collaboration of Observational HIV Epidemiological Research Euro; + view all
(2013)
Risk Factors and Outcomes for Late Presentation for HIV-Positive Persons in Europe: Results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE).
PLoS Med
, 10
(9)
, Article e1001510. 10.1371/journal.pmed.1001510.
|
|
|
Mondi, Annalisa;
Cozzi-Lepri, Alessandro;
Tavelli, Alessandro;
Cingolani, Antonella;
Giacomelli, Andrea;
Orofino, Giancarlo;
De Girolamo, Gabriella;
... ICONA Foundation Study Group; + view all
(2024)
Persistent poor clinical outcomes of people living with HIV presenting with AIDS and late HIV diagnosis - results from the ICONA cohort in Italy, 2009-2022.
International Journal of Infectious Diseases
, 142
, Article 106995. 10.1016/j.ijid.2024.106995.
|
|
Mondi, A;
Cozzi-Lepri, A;
Tavelli, A;
Rusconi, S;
Vichi, F;
Ceccherini-Silberstein, F;
Calcagno, A;
... Icona Foundation Study Group, .; + view all
(2019)
Effectiveness of dolutegravir-based regimens as either first-line or switch antiretroviral therapy: data from the Icona cohort.
Journal of the International AIDS Society
, 22
(1)
, Article e25227. 10.1002/jia2.25227.
|
|
|
Monforte, Antonella d'Arminio;
Tavelli, Alessandro;
Antinori, Andrea;
Cozzi-Lepri, Alessandro;
(2023)
Long-term outcome of dolutegravir-containing regimens according to sex: data from the ICONA Study–authors’ response.
Journal of Antimicrobial Chemotherapy
, 78
(7)
pp. 1809-1810.
10.1093/jac/dkad152.
|
|
Monforte, Antonella D'arminio;
Tavelli, Alessandro;
Sala, Matteo;
Mondi, Annalisa;
Rusconi, Stefano;
Antinori, Spinello;
Puoti, Massimo;
... Cozzi-Lepri, Alessandro; + view all
(2023)
Long-term outcome of dolutegravir-containing regimens according to sex: data from the ICONA study.
Journal of Antimicrobial Chemotherapy
, 78
(4)
pp. 933-945.
10.1093/jac/dkad026.
|
|
Monforte, AD;
Cozzi-Lepri, A;
Ceccherini-Silberstein, F;
De Luca, A;
Lo Caputo, S;
Castagna, A;
Mussini, C;
... Puoti, M; + view all
(2017)
Access and response to direct antiviral agents (DAA) in HIV-HCV co-infected patients in Italy: Data from the Icona cohort.
PLoS ONE
, 12
(5)
, Article e0177402. 10.1371/journal.pone.0177402.
|
|
|
Monforte, AD;
Cozzi-Lepri, A;
Maggiolo, F;
Rizzardini, G;
Manconi, PE;
Gianotti, N;
Quirino, T;
... Antinori, A; + view all
(2016)
Response to First-Line Ritonavir-Boosted Protease Inhibitors (PI/r)-Based Regimens in HIV Positive Patients Presenting to Care with Low CD4 Counts: Data from the Icona Foundation Cohort.
PLoS ONE
, 11
(6)
, Article e0156360. 10.1371/journal.pone.0156360.
|
|
Moro, ML;
Viganò, EF;
Cozzi Lepri, A;
(1994)
Risk factors for central venous catheter-related infections in surgical and intensive care units. The Central Venous Catheter-Related Infections Study Group.
Infect Control Hosp Epidemiol
, 15
(4)
253 - 264.
|
|
|
Mussini, C;
Cozzi-Lepri, A;
Menozzi, M;
Meschiari, M;
Franceschini, E;
Rogati, C;
Cuomo, G;
... Office of information and communication technologies of Policlin; + view all
(2021)
Better prognosis in females with severe COVID-19 pneumonia: possible role of inflammation as potential mediator.
Clinical Microbiology and Infection
, 27
(8)
pp. 1137-1144.
10.1016/j.cmi.2020.12.010.
|
|
Mussini, C;
Cozzi-Lepri, A;
Meschiari, M;
Franceschini, E;
Burastero, G;
Faltoni, M;
Franceschi, G;
... Guaraldi, G; + view all
(2023)
Do All Critically Ill Patients with COVID-19 Disease Benefit from Adding Tocilizumab to Glucocorticoids? A Retrospective Cohort Study.
Viruses
, 15
(2)
, Article 294. 10.3390/v15020294.
|
|
Mussini, Cristina;
Cozzi-Lepri, Alessandro;
(2022)
Another piece in the COVID-19 treatment puzzle.
Lancet
, 399
(10325)
pp. 609-610.
10.1016/S0140-6736(22)00154-4.
|
|
Mussini, C;
Antinori, A;
Bhagani, S;
Branco, T;
Brostrom, M;
Dedes, N;
Bereczky, T;
... Monforte, AD; + view all
(2016)
European AIDS Clinical Society Standard of Care meeting on HIV and related coinfections: The Rome Statements.
HIV Medicine
, 17
(6)
pp. 445-452.
10.1111/hiv.12347.
|
|
|
Mussini, C;
Cozzi-Lepri, A;
Menozzi, M;
Meschiari, M;
Franceschini, E;
Milic, J;
Brugioni, L;
... Guaraldi, G; + view all
(2021)
Development and validation of a prediction model for tocilizumab failure in hospitalized patients with SARS-CoV-2 infection.
PLOS ONE
, 16
(2)
, Article e0247275. 10.1371/journal.pone.0247275.
|
|
|
Mussini, C;
Lorenzini, P;
Cozzi-Lepri, A;
Mammone, A;
Guaraldi, G;
Marchetti, G;
Lichtner, M;
... Girardi, E; + view all
(2021)
Determinants of loss to care and risk of clinical progression in PLWH who are re-engaged in care after a temporary loss.
Scientific Reports
, 11
(1)
, Article 9632. 10.1038/s41598-021-88367-5.
|
|
|
Mussini, C;
Lorenzini, P;
Cozzi-Lepri, A;
Marchetti, G;
Rusconi, S;
Gori, A;
Nozza, S;
... Icona Foundation Study Group; + view all
(2018)
Switching to dual/monotherapy determines an increase in CD8+ in HIV-infected individuals: an observational cohort study.
BMC Med
, 16
(1)
, Article 79. 10.1186/s12916-018-1046-2.
|
|
|
Neesgaard, B;
Pelchen-Matthews, A;
Ryom, L;
Florence, E;
Peters, L;
Roen, A;
Svedhem, V;
... EuroSIDA study; + view all
(2019)
Uptake and effectiveness of two-drug compared with three-drug antiretroviral regimens among HIV-positive individuals in Europe.
AIDS
, 33
(13)
pp. 2013-2024.
10.1097/QAD.0000000000002320.
|
|
Nozza, S;
Cozzi-Lepri, A;
Bai, F;
Rusconi, S;
Gori, A;
Cinque, P;
Ammassari, A;
... Icona Foundation Study Group; + view all
(2017)
Proportion and factors associated with recent HIV infection in a cohort of patients seen for care in Italy over 1996-2014: Data from the ICONA Foundation Study cohort.
PLoS One
, 12
(12)
, Article e0189045. 10.1371/journal.pone.0189045.
|
|
|
Panayidou, K;
Davies, M-A;
Anderegg, N;
Egger, M;
Fatti, G;
Vinikoor, M;
Sawry, S;
... Siminski, S; + view all
(2018)
Global temporal changes in the proportion of children with advanced disease at the start of combination antiretroviral therapy in an era of changing criteria for treatment initiation.
Journal of the International AIDS Society
, 21
(11)
, Article e25200. 10.1002/jia2.25200.
|
|
|
Pelchen-Matthews, A;
Borges, ÁH;
Reekie, J;
Rasmussen, LD;
Wiese, L;
Weber, J;
Pradier, C;
... EuroSIDA study; + view all
(2021)
Prevalence and Outcomes for Heavily Treatment-Experienced (HTE) Individuals Living with Human Immunodeficiency Virus in a European Cohort.
JAIDS: Journal of Acquired Immune Deficiency Syndromes
, 87
(2)
pp. 806-817.
10.1097/QAI.0000000000002635.
|
|
Peters, L;
Cozzi-Lepri, A;
Hepatitis C Working Group for the Collaboration of Observational, .;
(2016)
Is Response to Anti-HCV Treatment Predictive of Mortality in HCV/HIV Positive Patients?
AIDS
, 31
(5)
pp. 661-668.
10.1097/QAD.0000000000001378.
|
|
Pett, S;
Simonsen, L;
Higgs, E;
Robert.J, T;
Wentworth, D;
Cozzi-Lepri, A;
Dwyer, DE;
... Lundgren, J; + view all
(2018)
Using Clinical Research Networks to Assess Severity of an Emerging Influenza Pandemic.
pp. 341-349.
10.1093/cid/ciy088.
|
|
Phillips, AN;
Staszewski, S;
Lampe, F;
Youle, MS;
Klauke, S;
Bickel, M;
Sabin, CA;
... Royal Free Ctr HIV Med Goethe Univ; + view all
(2002)
Human immunodeficiency virus rebound after suppression to < 400 copies/mL during initial highly active antiretroviral therapy regimens, according to prior nucleoside experience and duration of suppression.
JOURNAL OF INFECTIOUS DISEASES
, 186
(8)
1086 - 1091.
|
|
|
Puoti, M;
Lorenzini, P;
Cozzi-Lepri, A;
Gori, A;
Mastroianni, C;
Rizzardini, G;
Mazzarello, G;
... Icona Foundation Study Group, .; + view all
(2017)
Incidence and Progression to Cirrhosis of New HCV infections in Persons Living with HIV.
Clinical Microbiology and Infection
, 23
(4)
267.e1-267.e4.
10.1016/j.cmi.2016.12.003.
|
|
Reekie, J;
Kowalska, JD;
Karpov, I;
Rockstroh, J;
Karlsson, A;
Rakhmanova, A;
Horban, A;
... EuroSIDA in EuroCoord; + view all
(2012)
Regional differences in AIDS and non-AIDS related mortality in HIV-positive individuals across Europe and Argentina: the EuroSIDA study.
PLoS One
, 7
(7)
, Article e41673. 10.1371/journal.pone.0041673.
|
|
|
Rodari, Paola;
Tamarozzi, Francesca;
Tais, Stefano;
Degani, Monica;
Perandin, Francesca;
Buonfrate, Dora;
Nicastri, Emanuele;
... Angheben, Andrea; + view all
(2022)
Prevalence of Chagas disease and strongyloidiasis among HIV-infected Latin American immigrants in Italy – The CHILI study.
Travel Medicine and Infectious Disease
, 48
, Article 102324. 10.1016/j.tmaid.2022.102324.
|
|
|
Roen, A;
Laut, K;
Pelchen-Matthews, A;
Borodulina, E;
Caldeira, L;
Clarke, A;
Clotet, B;
... EuroSIDA study; + view all
(2018)
Abacavir usage patterns and hypersensitivity reactions in the EuroSIDA cohort.
HIV Medicine
, 19
(4)
pp. 252-260.
10.1111/hiv.12573.
|
|
Rohner, E;
Butikofer, L;
Schmidlin, K;
Sengayi, M;
Maskew, M;
Giddy, J;
Garone, D;
... Bohlius, J; + view all
(2017)
Comparison of Kaposi Sarcoma Risk in Human Immunodeficiency Virus-Positive Adults Across 5 Continents: A Multiregional Multicohort Study.
Clinical Infectious Diseases
, 65
(8)
pp. 1316-1326.
10.1093/cid/cix480.
|
|
Rossetti, B;
Bai, F;
Tavelli, A;
Galli, M;
Antinori, A;
Castelli, F;
Pellizzer, G;
... ICONA Foundation study group; + view all
(2017)
Evolution of the prevalence of hepatitis C virus infection and hepatitis C virus genotype distribution in human immunodeficiency virus-infected patients in Italy between 1997 and 2015.
Clin Microbiol Infect
10.1016/j.cmi.2017.07.021.
|
|
Ruggiero, A;
Cozzi-Lepri, A;
Beloukas, A;
Richman, D;
Khoo, S;
Phillips, A;
Geretti, AM;
(2018)
Factors Associated With Persistence of Plasma HIV-1 RNA During Long-term Continuously Suppressive Firstline Antiretroviral Therapy.
Open Forum Infect Dis
, 5
(2)
, Article ofy032. 10.1093/ofid/ofy032.
|
|
|
Rusconi, S;
Santoro, MM;
Gianotti, N;
Antinori, A;
Bonora, S;
Cingolani, A;
Ceccherini Silberstein, F;
... Icona Foundation Study Group, .; + view all
(2019)
Is the rate of virological failure to cART continuing to decline in recent calendar years?
[Rapid communication].
Journal of Clinical Virology
, 116
pp. 23-28.
10.1016/j.jcv.2019.04.009.
|
|
Santos, JR;
Cozzi-Lepri, A;
Phillips, A;
De Wit, S;
Pedersen, C;
Reiss, P;
Blaxhult, A;
... Lundgren, JD; + view all
(2018)
Long‐term effectiveness of recommended boosted protease inhibitor‐based antiretroviral therapy in Europe.
HIV Medicine
, 19
(5)
pp. 324-338.
10.1111/hiv.12581.
|
|
Saracino, A;
Cozzi-Lepri, A;
Shanyinde, M;
Ceccherini Silberstein, F;
Nozza, S;
Di Biagio, A;
Cassola, G;
... ICONA Foundation Study; + view all
(2018)
HIV-1 co-receptor tropism and liver fibrosis in HIV-infected patients.
PLoS One
, 13
(1)
, Article e0190302. 10.1371/journal.pone.0190302.
|
|
|
Saracino, A;
Zaccarelli, M;
Lorenzini, P;
Bandera, A;
Marchetti, G;
Castelli, F;
Gori, A;
... Lo Caputo, S; + view all
(2018)
Impact of social determinants on antiretroviral therapy access and outcomes entering the era of universal treatment for people living with HIV in Italy.
BMC Public Health
, 18
(870)
10.1186/s12889-018-5804-z.
|
|
|
Schultze, A;
Paredes, R;
Sabin, C;
Phillips, AN;
Pillay, D;
Mackie, N;
Castagna, A;
... Cozzi-Lepri, A; + view all
(2018)
The association between detected drug resistance mutations and CD4(+) T-cell decline in HIV-positive individuals maintained on a failing treatment regimen.
Antiviral Therapy
, 23
pp. 105-116.
10.3851/IMP3178.
|
|
Schultze, A;
Torti, C;
Cozzi-Lepri, A;
Vandamme, A-M;
Zazzi, M;
Sambatakou, H;
De Luca, A;
... European Transmitted Drug Resistance collaboration (EU-TDR); + view all
(2019)
The effect of primary drug resistance on CD4+ cell decline and the viral load set-point in HIV-positive individuals before the start of antiretroviral therapy.
AIDS
, 33
(2)
pp. 315-326.
10.1097/QAD.0000000000002046.
|
|
Shanyinde, M;
Girardi, E;
Puoti, M;
De Luca, A;
Sighinolfi, L;
Caterina, UF;
Caramello, P;
... ICONA Foundation Study Group; + view all
(2019)
Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection?
BMC Public Health
, 19
, Article 1291. 10.1186/s12889-019-7608-1.
|
|
Shepherd, L;
Borges, Á;
Ledergerber, B;
Domingo, P;
Castagna, A;
Rockstroh, J;
Knysz, B;
... EuroSIDA in EuroCOORD, E.E.; + view all
(2016)
Infection-related and -unrelated malignancies, HIV and the aging population.
HIV Medicine
, 17
10.1111/hiv.12359.
|
|
Shepherd, L;
Borges, AH;
Harvey, R;
Bower, M;
Grulich, A;
Silverberg, M;
Weber, J;
... Mocroft, A; + view all
(2018)
The extent of B-cell activation and dysfunction preceding lymphoma development in HIV-positive people.
HIV Medicine
, 19
(2)
pp. 90-101.
10.1111/hiv.12546.
|
|
Shepherd, LC;
Laut, K;
Pedersen, C;
Rockstroh, JK;
Sambatakou, H;
Paduta, D;
Matulionyte, R;
... EuroSIDA in EuroCoord, .; + view all
(2016)
Associations between HIV-RNA-based indicators and virological and clinical outcomes.
AIDS
, 30
(12)
pp. 1961-1972.
10.1097/QAD.0000000000001144.
|
|
Smit, M;
Cassidy, R;
Cozzi-Lepri, A;
Quiros-Roldan, E;
Girardi, E;
Mammone, A;
Antinori, A;
... Hallett, TB; + view all
(2017)
Projections of non-communicable disease and health care costs among HIV-positive persons in Italy and the USA: A modelling study.
PLoS ONE
, 12
(10)
, Article e0186638. 10.1371/journal.pone.0186638.
|
|
|
Spaziante, M;
Taliani, G;
Marchetti, G;
Tavelli, A;
Lichtner, M;
Cingolani, A;
Cicalini, S;
... Cozzi-Lepri, A; + view all
(2021)
Impact of HCV Eradication on Lipid Metabolism in HIV/HCV Coinfected Patients: Data from ICONA and HepaICONA Foundation Cohort Study.
Viruses
, 13
(7)
, Article 1402. 10.3390/v13071402.
|
|
|
Squillace, N;
Lorenzini, P;
Lapadula, G;
Bandera, A;
Cozzi-Lepri, A;
Rusconi, S;
Puoti, M;
... Icona Foundation Study Group; + view all
(2016)
Triglyceride/HDL ratio and its impact on the risk of diabetes mellitus development during ART.
J Antimicrob Chemother
, 71
(9)
pp. 2663-2669.
10.1093/jac/dkw185.
|
|
Surial, B;
Ramírez Mena, A;
Roumet, M;
Limacher, A;
Smit, C;
Leleux, O;
Mocroft, A;
... Peters, EJG; + view all
(2023)
External validation of the PAGE-B score for HCC risk prediction in people living with HIV/HBV coinfection.
Journal of Hepatology
, 78
(5)
pp. 947-957.
10.1016/j.jhep.2022.12.029.
(In press).
|
|
Taramasso, L;
Rossotti, R;
Tavelli, A;
Santoro, MM;
Mazzotta, V;
Bandera, A;
D'Ettorre, G;
... ICONA Foundation Study Group; + view all
(2025)
Brief Report: New HIV Diagnoses in PrEP-Experienced and PrEP-Naive Persons in the ICONA Cohort.
JAIDS: Journal of Acquired Immune Deficiency Syndromes
, 98
(4)
pp. 352-356.
10.1097/QAI.0000000000003576.
|
|
Taramasso, L;
Di Biagio, A;
Maggiolo, F;
Tavelli, A;
Lo Caputo, S;
Bonora, S;
Zaccarelli, M;
... Italian Cohort Naive Antiretrovirals (ICONA) Foundation Study Gr; + view all
(2018)
First-line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison.
HIV Medicine
, 19
(7)
pp. 475-484.
10.1111/hiv.12628.
|
|
Taramasso, L;
Lorenzini, P;
Di Biagio, A;
Lichtner, M;
Marchetti, G;
Rossotti, R;
Lapadula, G;
... ICONA Foundation Study Group; + view all
(2019)
Incidence and risk factors for liver enzyme elevation among naive HIV-1-infected patients receiving ART in the ICONA cohort.
Journal of Antimicrobial Chemotherapy
, 74
(11)
pp. 3295-3304.
10.1093/jac/dkz353.
|
|
Tavelli, A;
Vergori, A;
Cingolani, A;
Bai, F;
Azzini, AM;
Hara, GL;
Caponcello, MG;
... Cataudella, S; + view all
(2025)
ORCHESTRA Delphi consensus: clinical management of SARS-CoV-2 infection in people with HIV.
Clinical Microbiology and Infection
10.1016/j.cmi.2025.03.006.
(In press).
|
|
Tontodonati, M;
Cenderello, G;
Celesia, BM;
Trezzi, M;
Ursini, T;
Costantini, A;
Marra, D;
... Parruti, G; + view all
(2015)
Cost of HAART in Italy: multicentric evaluation and determinants from a large HIV outpatient cohort.
ClinicoEconomics and Outcomes Research
, 7
pp. 27-35.
10.2147/CEOR.S69183.
|
|
Valentina, Mazzotta;
Alessandro, Cozzi Lepri;
Francesca, Colavita;
Silvia, Rosati;
Eleonora, Lalle;
Claudia, Cimaglia;
Jessica, Paulicelli;
... INMI COVID-19 Outpatient Treatment Study Group; + view all
(2022)
Viral load decrease in SARS-CoV-2 BA.1 and BA.2 Omicron sublineages infection after treatment with monoclonal antibodies and direct antiviral agents.
Journal of Medical Virology
10.1002/jmv.28186.
(In press).
|
|
Varisco, Benedetta;
Bai, Francesca;
De Benedittis, Sara;
Tavelli, Alessandro;
Cozzi-Lepri, Alessandro;
Sala, Matteo;
Miraglia, Federica Gaia;
... Marchetti, Giulia; + view all
(2023)
EuCARE-POSTCOVID Study: a multicentre cohort study on long-term post-COVID-19 manifestations.
BMC Infectious Diseases
, 23
(1)
, Article 684. 10.1186/s12879-023-08595-0.
|
|
|
Vergori, Alessandra;
Cozzi-Lepri, Alessandro;
Matusali, Giulia;
Cicalini, Stefania;
Bordoni, Veronica;
Meschi, Silvia;
Mazzotta, Valentina;
... Antinori, Andrea; + view all
(2023)
Long Term Assessment of Anti-SARS-CoV-2 Immunogenicity after mRNA Vaccine in Persons Living with HIV.
Vaccines
, 11
(12)
, Article 1739. 10.3390/vaccines11121739.
|
|
Vergori, Alessandra;
Cozzi-Lepri, Alessandro;
Matusali, Giulia;
Colavita, Francesca;
Cicalini, Stefania;
Gallì, Paola;
Garbuglia, Anna Rosa;
... Antinori, Andrea; + view all
(2022)
SARS-CoV-2 Omicron Variant Neutralization after Third Dose Vaccination in PLWH.
Viruses
, 14
(8)
, Article 1710. 10.3390/v14081710.
|
|
|
Vergori, Alessandra;
Cozzi-Lepri, Alessandro;
Tavelli, Alessandro;
Mazzotta, Valentina;
Azzini, Anna Maria;
Gagliardini, Roberta;
Mastrorosa, Ilaria;
... Vax ICONA ORCHESTRA Study group; + view all
(2024)
SARS-CoV-2 mRNA vaccination and short-term changes in viral load and CD4/CD8 T-cell counts in people living with HIV.
International Journal of Infectious Diseases
, 144
, Article 107065. 10.1016/j.ijid.2024.107065.
|
|
|
Vergori, Alessandra;
Lepri, Alessandro Cozzi;
Chiuchiarelli, Marta;
Mazzotta, Valentina;
Metafuni, Elisabetta;
Matusali, Giulia;
Siciliano, Valentina;
... Cingolani, Antonella; + view all
(2024)
Risk of SARS-CoV-2 infection in patients with hematologic diseases receiving tixagevimab/cilgavimab as pre-exposure prophylaxis in most recent Omicron sublineages era.
International Journal of Infectious Diseases
, 144
, Article 107042. 10.1016/j.ijid.2024.107042.
|
|
Vergori, Alessandra;
Lepri, Alessandro Cozzi;
Cicalini, Stefania;
Matusali, Giulia;
Bordoni, Veronica;
Lanini, Simone;
Meschi, Silvia;
... Antinori, Andrea; + view all
(2022)
Immunogenicity to COVID-19 mRNA vaccine third dose in people living with HIV.
Nature Communications
, 13
, Article 4922. 10.1038/s41467-022-32263-7.
|
|
Vergori, Alessandra;
Matusali, Giulia;
Lepri, Alessandro Cozzi;
Cimini, Eleonora;
Fusto, Marisa;
Colavita, Francesca;
Gagliardini, Roberta;
... HIV-VAC Study group; + view all
(2023)
Neutralizing activity and T Cell response after bivalent fifth dose of mRNA vaccine in person living with HIV.
International Journal of Infectious Diseases
10.1016/j.ijid.2023.06.010.
(In press).
|
|
Vergori, A;
Gagliardini, R;
Gianotti, N;
Gori, A;
Lichtner, M;
Saracino, A;
De Vito, A;
... A Cozzi-Lepri on behalf of the Icona Foundation Study Network; + view all
(2020)
Switching from TDF to TAF or dual therapy (DT)-based regimens in HIV-infected individuals with viral load <=50 copies/ml: does eGFR matter?
International Journal of Antimicrobial Agents
, Article 106154. 10.1016/j.ijantimicag.2020.106154.
(In press).
|
|
|
Vergori, A;
Lorenzini, P;
Cozzi-Lepri, A;
Donno, DR;
Gualano, G;
Nicastri, E;
Iacomi, F;
... ReCOVeRI Study Group, .; + view all
(2021)
Prophylactic heparin and risk of orotracheal intubation or death in patients with mild or moderate COVID-19 pneumonia.
Scientific Reports
, 11
(1)
, Article 11334. 10.1038/s41598-021-90713-6.
|
|
|
Vourli, G;
Noori, T;
Pharris, A;
Porter, K;
Axelsson, M;
Begovac, J;
Cazein, F;
... European HIV Continuum of Care Working Group; + view all
(2020)
Human Immunodeficiency Virus Continuum of Care in 11 European Union Countries at the End of 2016 Overall and by Key Population: Have We Made Progress?
Clinical Infectious Diseases
, 71
(11)
pp. 2905-2916.
10.1093/cid/ciaa696.
|
|
|
Wang, Q;
De Luca, A;
Smith, C;
Zangerle, R;
Sambatakou, H;
Bonnet, F;
Smit, C;
... Hepatitis Coinfection and Non Hodgkin Lymphoma project team for; + view all
(2016)
Chronic Hepatitis B and C Virus Infection and Risk for Non-Hodgkin Lymphoma in HIV-Infected Patients: A Cohort Study.
Annals of Internal Medicine
, 166
(1)
pp. 9-17.
10.7326/M16-0240.
|
|
Willemse, S;
Smit, C;
Sogni, P;
Sarcletti, M;
Uberti-Foppa, C;
Wittkop, L;
Raben, D;
... Hepatocellular Carcinoma Screening Project Working Group for the; + view all
(2019)
Low compliance with hepatocellular carcinoma screening guidelines in hepatitis B/C virus co-infected HIV patients with cirrhosis.
Journal of Viral Hepatitis
, 26
(10)
pp. 1224-1228.
10.1111/jvh.13146.
|
|
|
Wittkop, L;
Arsandaux, J;
Trevino, A;
van der Loeff, MS;
Anderson, J;
van Sighem, A;
Boni, J;
... ACHIeV2e, .; + view all
(2017)
CD4 cell count response to first-line combination ART in HIV-2+patients compared with HIV-1+patients: a multinational, multicohort European study.
Journal of Antimicrobial Chemotherapy
, 72
(10)
pp. 2869-2878.
10.1093/jac/dkx210.
|
|
Worm, SW;
Bower, M;
Reiss, P;
Bonnet, F;
Law, M;
Fätkenheuer, G;
d'Arminio Monforte, A;
... D:A:D Study Group; + view all
(2013)
Non-AIDS defining cancers in the D:A:D Study - time trends and predictors of survival: a cohort study.
BMC Infectious Diseases
, 13
(Octobe)
, Article 471. 10.1186/1471-2334-13-471.
|
|
|
Young, J;
Psichogiou, M;
Meyer, L;
Ayayi, S;
Grabar, S;
Raffi, F;
Reiss, P;
... Grp, EAIDST; + view all
(2012)
y CD4 Cell Count and the Risk of AIDS or Death in HIV-Infected Adults on Combination Antiretroviral Therapy with a Suppressed Viral Load: A Longitudinal Cohort Study from COHERE.
PLoS Medicine
, 9
(3)
, Article e1001194. 10.1371/journal.pmed.1001194.
|
|
|
Zoufaly, A;
Cozzi-Lepri, A;
Reekie, J;
Kirk, O;
Lundgren, J;
Reiss, P;
Jevtovic, D;
... Van Lunzen, J; + view all
(2014)
Immuno-Virological Discordance and the Risk of Non-AIDS and AIDS Events in a Large Observational Cohort of HIV-Patients in Europe.
PLoS One
, 9
(1)
, Article e87160. 10.1371/journal.pone.0087160.
|
|
